Approval · Notice of Compliance 18331 · 2016
STAXYN: Notice of Compliance 18331
Issued July 27, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18331
- Date
- July 27, 2016
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To convert the packaging from a sliding blister sleeve to a standard blister format
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| STAXYN | Not yet assigned | — |
Medicinal ingredients
- VARDENAFIL HYDROCHLORIDE 11.85 MG per TAB